Evidence map›Paper›PMID 29281723›Full record

ArticlePLoS pathogens2017

Human immunodeficiency virus type-1 (HIV-1) evades antibody-dependent phagocytosis.

Johannes S Gach, Margaux Bouzin, Marcus P Wong, Veronika Chromikova, Andrea Gorlani, Kuan-Ting Yu, Brijesh Sharma, Enrico Gratton, Donald N Forthal

Open access · goldAbstract read
In one paragraph

Article in PLoS pathogens, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
1.4field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 26 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Nanoparticles presenting clusters of CD4 expose a universal vulnerability of HIV-1 by mimicking target cells.Proceedings of the National Academy of Sciences of the United States of America · 2020
    Article
  14. Review
  15. Review
  16. Article
  17. Review
  18. Review
  19. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Johannes S GachDepartment of Medicine, Division of Infectious Diseases, University of California, Irvine School of Medicine, Irvine, California, United States of America.
Margaux BouzinDepartment of Biomedical Engineering, University of California, Irvine, Irvine, California, United States of America.
Marcus P WongDepartment of Medicine, Division of Infectious Diseases, University of California, Irvine School of Medicine, Irvine, California, United States of America.
Veronika ChromikovaDepartment of Microbiology, Icahn School of Medicine at Mount Sinai, New York, New York, United States of America.
Andrea GorlaniDepartment of Medicine, Division of Infectious Diseases, University of California, Irvine School of Medicine, Irvine, California, United States of America.
Kuan-Ting YuDepartment of Medicine, Division of Infectious Diseases, University of California, Irvine School of Medicine, Irvine, California, United States of America.ORCID 0000-0002-4189-291X
Brijesh SharmaDepartment of Medicine, Division of Infectious Diseases, University of California, Irvine School of Medicine, Irvine, California, United States of America.ORCID 0000-0002-9587-2092
Enrico GrattonDepartment of Biomedical Engineering, University of California, Irvine, Irvine, California, United States of America.
Donald N ForthalDepartment of Medicine, Division of Infectious Diseases, University of California, Irvine School of Medicine, Irvine, California, United States of America.ORCID 0000-0001-6687-6775
University of California, Irvine · USFluor (United States) · USIcahn School of Medicine at Mount Sinai · US

Funding

Uncover Strategies Used By Biological SystemsP50GM076516 · NIGMS · UNIVERSITY OF CALIFORNIA-IRVINE · PI NIE, QING · 2007 to 2016
$25.1M
TRD4: Phasor analysisP41GM103540 · NIGMS · UNIVERSITY OF CALIFORNIA-IRVINE · PI GRATTON, ENRICO · 2012 to 2020
$12.5M
The role of antibody and the Fc neonatal receptor in transmitted/founder strain selectionR01AI118581 · NIAID · UNIVERSITY OF CALIFORNIA-IRVINE · PI FORTHAL, DONALD N · 2015 to 2019
$2.9M
Impact of antibody mediated phagocytosis on HIV-1 clearanceR03AI118547 · NIAID · UNIVERSITY OF CALIFORNIA-IRVINE · PI GACH, JOHANNES S · 2015 to 2016
$155k
Austrian Science Fund FWF W 1224NIAID NIH HHS R01 AI118581NIAID NIH HHS R03 AI118547NIGMS NIH HHS P41 GM103540NIGMS NIH HHS P50 GM076516NIH HHS P41GM103540NIH HHS P50GM076516NIH HHS R03AI118547
6 · The paper itself

Abstract

Fc gamma receptor (FcyR)-mediated antibody functions play a crucial role in preventing HIV infection. One such function, antibody-dependent phagocytosis (ADP), is thought to be involved in controlling other viral infections, but its role in HIV infection is unknown. We measured the ability of HIV-specific polyclonal and monoclonal antibodies (mAbs) to mediate the internalization of HIV-1 virions and HIV-1-decorated cells by phagocytes. To measure ADP of virions, we primarily used a green-fluorescent protein-expressing molecular clone of HIV-1JRFL, an R5, clinical isolate, in combination with polyclonal HIVIG or mAbs known to capture and/or neutralize HIV-1. THP-1 and U937 cells, as well as freshly isolated primary monocytes from healthy individuals, were used as phagocytic effector cells, and uptake of virions was measured by cytometry. We surprisingly found minimal or no ADP of virions with any of the antibodies. However, after coating virions with gp41 or with gp41-derived peptides, gp41- (but not gp120-) specific mAbs efficiently mediated phagocytosis. We estimated that a minimum of a few hundred gp41 molecules were needed for successful phagocytosis, which is similar to the number of envelope spikes on viruses that are readily phagocytosed (e.g. influenza virus). Furthermore, by employing fluorescence correlation spectroscopy, a well-established technique to measure particle sizes and aggregation phenomena, we found a clear association between virus aggregation and ADP. In contrast to virions themselves, virion-decorated cells were targets for ADP or trogocytosis in the presence of HIV-specific antibodies. Our findings indicate that ADP of virions may not play a role in preventing HIV infection, likely due to the paucity of trimers and the consequent inability of virion-bound antibody to cross-link FcyRs on phagocytes. However, ADP or trogocytosis could play a role in clearing HIV-infected cells and cells on the verge of infection.

Indexed as

HIV-1Antibodies, MonoclonalCell LineHEK293 CellsHIV AntibodiesHIV Envelope Protein gp41HIV InfectionsHost-Pathogen InteractionsHumansImmune EvasionPhagocytosisU937 CellsVirus InternalizationAntibodies, Monoclonalgp41 protein, Human immunodeficiency virus 1HIV AntibodiesHIV Envelope Protein gp41

Identifiers

PMID29281723
PMCPMC5760106
OpenAlexW2779871467

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.